24.48000 USD
0.72
2.86%
Last update Dec 18, 3:59 PM EST
Post-market
Day range
24.25
25.74000
Previous close
25.20000
Open
25.31000
Access this stock data via API
Subscribe
Apellis Pharmaceuticals Inc.
24.48
0.72
2.86%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 781.4M 396.6M 75.4M 66.6M
Cost of revenue 117.7M 58.5M 5.6M 5.2M
Gross profit 663.6M 338.1M 69.8M 61.4M
Operating expense
Research & development 327.6M 354.4M 387.2M 420.9M
Selling general and admin 501.1M 500.8M 277.2M 176.8M
Other operating expenses
Operating income -165.0M -517.1M -594.6M -536.3M
Non operating interest income
Income 12.8M 20.9M 8.9M 418K
Expense 40.4M 29.6M 32.6M 13.2M
Other income expense -4.1M -727K -33.2M -196.9M
Pretax income -196.7M -526.5M -651.5M -746.0M
Tax provision 1.2M 2.1M 669K 352K
Net income -197.9M -528.6M -652.2M -746.4M
Basic EPS -1.6 -4.5 -6.2 -8.8
Diluted EPS -1.6 -4.5 -6.2 -8.8
Basic average shares 123.9M 118.7M 106.1M 84.4M
Diluted average shares 123.9M 118.7M 106.1M 84.4M
EBITDA -152.6M -495.2M -584.5M -533.0M
Net income from continuing op. -197.9M -528.6M -652.2M -746.4M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 2 hours 53 minutes

17:07
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).